Find Your MAC! Add TransLabs as a preferred
source on Google
Novitas Reimbursement Caps

Novitas Reimbursement Caps: Overcoming Rural Laboratory Financial Strains in Mississippi

Rural Mississippi labs operate on thin margins while facing Medicare payment cuts scheduled for 2027. Those claims run through Novitas Solutions, the Medicare Administrative Contractor for Jurisdiction H, whose coverage policies and coding rules govern every submission. Although the Consolidated Appropriations Act of 2026 delayed Clinical Laboratory Fee Schedule reductions this year, cuts of up to 15% resume from 2027 through 2029. Because labs meeting applicable laboratory thresholds had to report private payer data by July 31, 2026, missing that deadline directly affects future reimbursement rates. Quarterly coding updates, pharmacogenomics criteria, and Technical and Component modifier errors add further denial risk on top of that. To manage all of this, labs should track Novitas updates, prepare PAMA reporting early, and build structured denial management workflows. Partnering with a Mississippi lab billing specialist like TransLabs helps labs absorb the coming reductions.

Running a lab in rural Mississippi isn’t easy. You’re trying to accommodate communities that have nowhere else to turn at a time when Medicare rules aren’t much more favorable. And here’s the most frustrating part: even a single coding error can result in revenue loss that disrupts your cash flow for weeks.

However, your lab can prevent that if you understand the Novitas reimbursement caps. This resulted from an important move when Congress hit pause on the worst of the cuts for this year. But, as 2027 begins, Congress may announce reimbursement cuts. Here, we’ll discuss the best financial strategy to manage this situation and how getting Mississippi laboratory billing services helps you streamline your revenue cycle.

Don’t Let a Single Coding Error Drain Your Cash Flow.

What are Novitas Reimbursement Caps for Mississippi Labs in 2026?

Novitas Solutions is the Medicare Administrative Contractor, or MAC, for Jurisdiction H, which covers seven states, including Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

Novitas has held this contract since 2012 and was just re-awarded the Jurisdiction H contract again in June 2026, so it’s managing claims for labs. Every clinical laboratory test your Mississippi facility bills to Medicare flows through Novitas’ coverage policies, coding rules, and payment schedules. It’s important to follow Novitas’ policy updates, so you don’t miss out on important changes that impact your revenue cycle.

New Reimbursement Caps

On February 3, 2026, President Trump signed the Consolidated Appropriations Act (CAA), 2026, into law. Section 6226 of that bill gave laboratories a much-needed breather by delaying the next round of Clinical Laboratory Fee Schedule (CLFS) payment cuts under the Protecting Access to Medicare Act (PAMA).

It means that CMS doesn’t reduce CLFS payments in 2026 and labs are safe this year, but a 15% reduction is expected in 2027. And it’s expected to reduce each year by 15% in 2028 and 2029.
For a rural Mississippi lab, it’s a huge financial hit. It could be the difference between staying open and shutting your doors.

The 2026 PAMA Data Reporting Window

The PAMA window runs from May 1 through July 31, 2026.

Under the updated timeline, applicable laboratories must report private payer rate data collected between January 1, 2025, and June 30, 2025. This data feeds directly into how CMS calculates the weighted median rates used to set your future CLFS payments.
For smaller and rural labs, it isn’t optional, and it isn’t a task that you can perform any day. If your lab meets the definition of an applicable laboratory (which, generally, means you received more than a threshold amount of Medicare revenue from CLFS and Physician Fee Schedule services in the prior period), you’re obligated to report.

And that’s important because labs underreported, due to which original PAMA rates hugely impacted rural and hospital outreach labs back in 2018. When only a few labs report, the resulting median calculates the data based on only those labs that showed up. And these are mostly large national reference labs. That’s bad news for smaller, independent, and rural facilities.

If your lab meets the applicable laboratory requirements, you must register with CMS, pull private payer and volume data from January to June 2025, cross-check your figures against the CMS reporting template, and report your findings before the July 31, 2026 deadline.

How Local Coverage Determination Impacts Reimbursement?

Novitas revises its LCDs and billing and coding articles on a rolling basis for Jurisdiction H, and molecular and genetic testing categories see the most frequent activity. Two important policies for Mississippi labs are:

  • Pharmacogenomics Testing (LCD L39063 and Article A58801): This policy lays out medical necessity criteria for pharmacogenomic tests, including which drug-gene pairs are considered actionable and what documentation Medicare expects.
  • Molecular Pathology and Genetic Testing (Article A58917): This article covers coding rules for molecular pathology claims and gets refreshed each quarter to reflect new CPT and HCPCS codes.

Novitas and other MACs roll coding article changes out on a quarterly cycle, tied to the CPT and HCPCS code updates CMS releases throughout the year. That’s exactly a policy that was in practice the previous quarter can trip up your claims this quarter if you’re not following up with the update logs.

To put it simply, your claim bounces back denied. Then your staff has to find the denial reason, correct the code or documentation, and resubmit or appeal. Multiply that across dozens of claims a month, and it’s a serious cash flow drag. For a lab running on thin margins, it isn’t a feasible solution.

How Rural Mississippi Labs Feel the Biggest Impact?

Mississippi’s rural healthcare landscape is under real strain. According to a PBS News article from 2022, Mississippi state health officials stated that more than half (54%) of the state’s rural hospitals were at risk of closing, and Mississippi has lost inpatient care at more rural facilities than nearly any other state since 2010. The situation worsened in the coming years. In 2025, the Governor of Mississippi, Tate Reeves, reported that seven of the state’s counties don’t have a single hospital and residents lack patient care.

Recent industry tracking also found Mississippi has one of the highest shares of rural hospitals operating in the red across the entire country, and non-expansion states like Mississippi consistently lag behind expansion states on operating margins. When the hospital struggles, the lab attached to it struggles right along with it.

This scenario doesn’t get any better if there is a Technical Component versus Professional Component (TC/26) modifier mix-up on the Mississippi Locality 00 fee schedule. It can wipe out the margin on an entire batch of tests in one swoop.

What are the Actionable RCM Strategies for Mississippi Laboratories?

Here are the professional ways through which you can protect the revenue for your lab in The Hospitality State.

Bring in Dedicated Billing Expertise

Handling Novitas’ modifier rules, the Mississippi Locality 00 fee schedule, and quarterly CPT updates in-house is a full-time job, along with the regular duties you perform in your lab. Partnering with a lab RCM specialist, such as TransLabs, solves that issue. These billing teams don’t just closely observe the updates, but also implement them in daily RCM workflows, making sure that you submit compliant and clean claims that get approved. It also frees up your internal team to focus on patient results instead of watching for and fixing claim denials.

Stay On Top of Novitas Policy Updates and Protect Your Claims with Mississippi RCM Support.

Monitor LCDs Proactively

You shouldn’t look for policy changes after a claim denial comes your way. Check the CMS Medicare Coverage Database and the Novitas Jurisdiction H update log on a regular schedule, not just when a situation like that happens.

Get Your PAMA Reporting Squared Away Early

Waiting until late July to start pulling 2025 private payer data isn’t the right way. Build a system now that automates the collection and validation of that information, so you can easily submit the report.

Build a Real Denial Management Process

Every denial has a root cause, which could be missing documentation, a wrong modifier, or an outdated code. Just track whatever it is. A rapid-response denial management process catches patterns before they become a habit that quietly drains your revenue every month.

Prepare Now for the 2027 Cliff

The 2026 relief is temporary. Use this window to shore up your billing accuracy, tighten your coding compliance, and build a cash reserve where you can. When the 15% reductions start phasing in for 2027, labs that prepared ahead of time will weather it far better than those caught flat-footed.

Conclusion

Mississippi’s rural laboratories have a narrow window to get their revenue cycle in order before the 15% reductions start rolling in for 2027 through 2029. Between PAMA reporting deadlines, ever-changing Novitas LCDs, and the razor-thin margins rural facilities already operate on, there’s no room left for guesswork.

The labs that come out ahead are those that tighten their billing accuracy, stay on top of every coding update, and partner with RCM specialists. Now is the time to get that foundation solid, before 2027 shows up uninvited.

Frequently Asked Questions

What is the Novitas Jurisdiction H reimbursement cap for 2026?

The Consolidated Appropriations Act, 2026 delayed all CLFS phase-in payment reductions through the end of 2026, so labs in Jurisdiction H, including Mississippi, won’t see cuts under this rule until 2027.
Novitas administers Jurisdiction H, which includes Arkansas, Colorado, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas. Novitas also runs Jurisdiction L, covering Delaware, New Jersey, Pennsylvania, Maryland, and Washington, D.C.
Starting January 1, 2027, and continuing through 2029, CLFS payments for clinical diagnostic laboratory tests may be reduced by up to 15% per year compared to the prior year’s payment amount.
Applicable laboratories, generally those that received Medicare revenue above CMS’s set threshold from CLFS and Physician Fee Schedule services during the data collection period, must report private payer rate and volume data between May 1 and July 31, 2026.
Rural labs often operate on thinner margins tied to hospitals already struggling financially. State officials have flagged over half of Mississippi’s rural hospitals as being at risk of closure, and a single coding error or missed LCD update can wipe out the margin on an entire batch of Medicare claims.
Novitas typically revises coding articles like Molecular Pathology and Genetic Testing on a quarterly basis to reflect new CPT and HCPCS codes released by CMS throughout the year, so labs need ongoing monitoring rather than a one-time policy check.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!